2016

GSK opens new global vaccines R&D center in Rockville, Maryland

Tuesday, December 13, 2016

GlaxoSmithKline will inaugurate its newest global vaccines research and development (R&D) center in Rockville, Maryland, further strengthening and expanding its vaccines presence in the USA. Up to 200 new jobs will be created at the Rockville facility, with GSK investing over $50 million in the next two years to continue to develop the site with latest state-of-the-art scientific research technology and equipment.

[Read More]

Neurimmune, TVM Capital Life Science launch AL-S Pharma

Tuesday, December 13, 2016

Neurimmune and TVM Capital Life Science’s latest fund, TVM Life Science Ventures VII, has announced their investment in AL-S Pharma, a company based in Schlieren/Zurich, Switzerland. AL-S Pharma will develop, to proof-of-concept, AP-101, a human monoclonal antibody targeting misfolded SOD1 for the treatment of amyotrophic lateral sclerosis (ALS) that was generated and preclinically validated by Neurimmune’s Reverse Translational Medicine platform.

[Read More]

AstraZeneca eliminates 700 positions

Tuesday, December 13, 2016

AstraZeneca will transform its U.S. Commercial business as part of the company’s return to growth strategy. Following the company’s Year End Results announcement this past February, these changes reflect the ongoing focus to further streamline and drive greater efficiency across the entire organization. AstraZeneca continues to face loss of exclusivity impacts from many of its legacy products and works to compete in an ever-changing external environment. By diligently prioritizing, AstraZeneca will continue to successfully launch and commercialize new medicines, meet the needs of our customers and patients, and ultimately help AstraZeneca return to growth.

[Read More]

Major General James Gilman, M.D., to lead NIH Clinical Center

Monday, December 12, 2016

NIH Director Francis S. Collins, M.D., Ph.D., has announced the selection of Major General James K. Gilman, M.D., U.S. Army (Retired), as the inaugural chief executive officer of the NIH Clinical Center, the nation’s largest hospital devoted to clinical research. Dr. Gilman is expected to join in early January 2017.

[Read More]

ERT acquires Exco InTouch

Monday, December 12, 2016

ERT, a provider of high-quality patient data collection solutions for use in clinical drug development, has announced the acquisition of Exco InTouch, a provider of patient engagement, data capture and digital health solutions. The combined organization will provide the biopharmaceutical industry with the most advanced and comprehensive choice for electronic clinical outcome assessments (eCOA), patient engagement and digital health.

[Read More]

Social listening or patient panels?

Monday, December 12, 2016

The Pulse on Patient Recruitment by Ashley Tointon

With patient engagement activities ramping up in the clinical trials industry, sponsors are looking at different methods to engage patients. Two popular tactics—social listening and patient panels—are being conducted more regularly to gain insights into patients’ perceptions. Both tactics are valuable to learn from: Social listening is passive listening and patient panels are active engagement.

[Read More]